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Abstract An easy, rapid, and sensitive anodic stripping voltammetric method with a
controlled growth mercury drop electrode has been developed and validated for the
determination of Zn2+ ions in brain microdialysate samples obtained from rats. The
considered level of the zinc concentration in the dialysate was 0.5–6 ppb. In the investigated
method, the stripping step was carried out by using a differential pulse potential-time
voltammetric excitation signal. The optimal experimental conditions as well as the
instrumental and accumulation parameters and supporting electrolyte composition were
investigated. The optimized method was validated for precision, linearity, and accuracy. Mean
recovery 82–110% was achieved, the precision expressed by CV not greater than 7.6% and
the linearity given by correlation coefficient not lower than 0.9988. The limit of detection was
0.1 ppb. No interferences were observed. Due to high linearity, precision, and sensitivity, the
developed method may be successfully applied in the determination of zinc ions in
microdialysate brain samples. The results obtained for the first time demonstrate detailed
characteristics of the determination of zinc in the brain microdialysate fluid by the ASV
method. It may be applied in a wide range of physiological and pharmacological studies
which focus on very low zinc concentration/alteration in various compartments of the
organisms.
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Introduction
Zinc is a key component of many proteins and a co-factor of many enzymes that take part
in the important role of the brain’s function [1–3]. Zinc in the brain is mainly located in the
hippocampus, amygdala, and cerebral cortex. The majority of brain zinc is bound to zinc
metalloproteins, while the rest is present in presynaptic vesicles [4]. Neurons containing
these vesicles are termed zinc-enriched neurons (ZEN) and in the above-mentioned brain
areas, the ZEN terminals are glutamatergic [5]. By inhibiting both the GABA and
glutamatergic receptors, zinc seems to modulate neuronal excitability [3, 6] and is also
thought to play an important role in synaptic plasticity [7]. Recent data points to zinc as a
signaling molecule modulating protein function [8–11]. Zinc deficiency (e.g., dietary
deprivation) influences zinc homeostasis in the brain and leads to behavioral disturbances,
such as anorexia, dysphoria, impaired learning and cognitive function [4], and some
neurological disorders [4, 12]. The studies of the neuromodulatory role of zinc in the
synapse are based on the determination of zinc concentration in the extracellular fluid using
the microdialysis technique in different brain areas. Brain microdialysis is the in vivo
method to evaluate physiological concentration and the effect of various factors (e.g., drugs,
stress) on extracellular concentration of a variety of endogenous and/or exogenous
compounds [13, 14]. The concentration of zinc in the brain dialysates was determined by
the following methods: flame atomic absorption spectrometry [15, 16], fluorescence
spectrometry [17], and ligand-trapping technique [18]. The main limitation of these
methods is the low volume of the microdialysate probe (5–20 μl) and low zinc
concentration (μg/l level), and moreover, the necessity to separate and concentrate the
zinc ions during the preparation of the probe.
Stripping voltammetry (SV) analysis is a powerful and simple tool to determine trace
target metal species [19]. SV methods are widely applied in biomedical and pharmacolog-
ical analysis [20–23] as well as in the analysis of metals [23–25]. The major advantage of
SV compared with a direct voltammetric measurement is the preconcentration factor [26,
27]. In trace analysis of metal ions, anodic stripping voltammetry (ASV) is the most
popular SV technique. It is very important that ASV enables in situ zinc preconcentration in
a measured dialysate, which is not possible with the other analytical techniques. In ASV,
only free and hydrated Zn ions are accumulated, and this information is useful, for example,
in the diagnostics and pharmacotherapy of depression. Sowa-Kucma et al. observed the
increase in the concentration of zinc ions in the brain microdialysate after chronic
administration of the antidepressant drugs [28]. Likewise, Opoka et al. demonstrated that
single intraperitoneal administration of zinc induces an increase in extracellular zinc
concentration in the rat prefrontal cortex, which indicates the fast penetration of zinc
through the blood/brain barrier [29].
In this work, differential pulse anodic stripping voltammetry (DPASV) with the control
growth mercury drop electrode (CGMDE) is applied for the quantitative determinations of
zinc(II) ions in the brain microdialysate samples (matrix). DPASV is considered a
convenient method of voltammograms registration because of the wide range of linearity,
excellent reproducibility, low experimental cost, and the attainment of a low detection limit.
Also the CGMDE is the electrode of preference due to its high sensitivity, reproducibility,
and linearity [30]. No sample preparation is required except the pretreatment intended to
destroy organic compounds (complexants and organic surfactants). To control the proposed
method of determination, the standard addition method has been chosen. The presentation
of the optimized methodology and validation of the voltammetric method of Zn(II)
determination were the main purpose of this paper. The method was fully validated
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according to ICH guidelines [31–33] and may be successfully applied for the determination
of Zn in brain microdialysate samples.
Experimental
Instrumentation and Software
An Electrochemical Analyzer M161 with the electrode standM164 (bothMTM-ANKO, Poland)
were used for all voltammetric measurements. The classical three-electrode quartz cell, volume
5 ml, consisting of the CGMDE type M164 (MTM-ANKO, Poland) with the surface area of
1.8 mm2 as a working electrode, used in the hanging mercury drop electrode mode, a double
junction reference electrode Ag/AgCl/3M KCl with replaceable outer junction (2 M KNO3) and
a platinum wire as an auxiliary electrode. pH measurements were performed with a laboratory
pH-meter. All solutions used for analyses were purged with argon. A magnetic Teflon-coated
bar was used for stirring (approx. 600 rpm.) during the accumulation period. Experiments were
carried out at room temperature. The MTM-ANKO EAGRAPH software enabled electro-
chemical measurements, data acquisition, and advanced processing of the results.
Reagents and Solutions
All solutions and the sample preparation were realized with quadruply distilled water (last two
stages from quartz). HNO3 65% and KNO3 (Merck, Suprapur®) were used for the preparation
of samples and supporting electrolyte. Also Zn(II) standard stock solution (1,000 mg l−1,
Merck) was applied. Solutions with lower zinc concentrations were prepared just before the
measurements. Brain microdialysate samples were supplied by the Department of
Neurobiology, Institute of Pharmacology, Polish Academy of Sciences, Poland. Prior to
use, all glassware and, if necessary, the electrode’s body were cleaned by immersion in a 6 M
nitric acid, followed by copious rinsing in distilled water to avoid contamination.
In Vivo Microdialysis
The experiments were carried out on male rats (280–320 g). All procedures were conducted
in compliance with the National Institutes of Health Animal Care and Use Committee
guidelines and were approved by the Ethics Committee of the Institute of Pharmacology
Polish Academy of Sciences (Cracow, Poland).
The samples were obtained from the rat’s brain using in vivo microdialysis technology.
One day before the microdialysis experiment, the rats were anesthetized with ketamine
(75 mg/kg i.m.) and xylazine (10 mg/kg i.m.) and placed into a stereotaxic apparatus
(David Kopf Instruments, Tujunga, CA). The scalp was retracted and holes drilled through
the skull for insertion of a vertical microdialysis probe into the examined brain region (e.g.,
prefrontal cortex). Microdialysis probes were constructed by inserting two fused silica tubes
(30 and 35 mm long, 150 μm outer diameter (o.d.); Polymicro Technologies Inc., Phoenix,
AZ) into a Microdialysis fiber (220 μm o.d.; AN69, Hospal, Bologna, Italy). The tube
assembly was placed in a stainless steel cannula (22 gauge, 10 mm), forming the shaft of
the probe. Portions of the inlet and outlet tubes were individually placed inside
polyethylene PE-10 tubing and were glued for protection.
One day after the surgery and probe implantation, the inlet of the dialysis probes was
connected to a syringe pump (BAS, IN, USA) which delivered an artificial cerebrospinal
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fluid composed of [in mM]: NaCl 145, KCl 2.7, MgCl2 1.0, CaCl2 1.2; pH=7.4 at a flow
1.5 μl min–1. After 3 h of a washing period, when the extracellular level of zinc became
stable, samples were collected every 40 min from freely moving animals.
Sample Preparation
Brain microdialysate samples were transferred, immediately after they were collected,
directly into a miniature quartz tube and were acidified with nitric acid by the addition of
μl HNO3 (conc.) to each 20 μl of sample. The quartz tubes were kept at room
temperature, and the microdialysate samples were measured at a minimum of 24 h intervals
after acidification. Of the microdialysate, 0.05 ml was introduced into the electrochemical
cell containing the supporting electrolyte. The intention of the pretreatment was to destroy
organic compounds (complexants and organic surfactants).
DPASV Procedure
The stripping was performed in the differential pulse (DP) mode. Before the measurements,
the voltammetric cell was conditioned in 0.1 M nitric acid, rinsed with distilled water, and
shortly conditioned in supporting electrolyte. Of 0.05 M KNO3, 5 ml was added in the
electrochemical cell as a blank, and the solution was purged with the argon of 99.995%
purity for at least 5–7 min. The preconcentration step was carried out from the stirred
solution for a period of tacc=60 s at Eacc=−1.15 V versus Ag/AgCl electrode, at a fresh
mercury drop. After a rest period of 5 s, the differential pulse voltammogram was recorded
in the anodic direction from −1,150 to −750 mV with a potential scan rate of 25 mV s−1 and
pulse amplitude of −30 mV. The voltammogram for the blank solution demonstrates the
electrochemical cell and supporting electrolyte purity. Then, 20 or 50 μl of a sample
solution (brain microdialysate) was added to the cell while maintaining an argon
atmosphere over the solution before the differential pulse voltammograms were recorded.
All measurements were performed in the same conditions.
Methodology for Validation
Validation of an analytical method is the process by which it is established, by laboratory
studies, so that performance characteristics of the method meet the requirements for the
intended analytical applications. The elements required for method validation are: linearity
range, limit of detection, accuracy, precision, and selectivity. Validation was carried out
according to available guidelines [31–33] and refers to the following aspects.
Selectivity
There is no problem with selectivity because in the potential region used no other signal
apart from Zn is observed. These remarks confirm the selectivity of the method.
Precision
Precision was evaluated through repeatability of the final determined concentration and
repeatability of the signal (expressed by the Zn peak height) recorded for the sample. Four
different microdialysate extracts were chosen for experiments which contain various
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concentrations of Zn. Three to five replicates were realized for each sample. Determinations
were made in double experimental sessions (within a day and repeated the successive day,
delayed by a minimum 24 h interval). The sample was stored between sessions in a HNO3
environment. This leads to evaluation of the influence of the organic matter which may be
present in the solution in the trace concentration. The procedure evaluates together the
variability of the sample preparation operations, storage, and the variability of the Zn
determination.
Precision was expressed as standard deviations and coefficient of variability (CV)
calculated for Zn peak heights and as standard deviations and coefficient of variability of
the determined concentration of Zn.
Accuracy
Due to the fact that a brain’s microdialysate samples are not commercially available as a
CRM, and taking into account the influence of the matrix on the recorded signal, the
accuracy was tested by the calculation of the recovery of the added Zn standard to the real
sample. Three different microdialysate extracts were chosen for experiments that contain
various concentrations of Zn. The standard addition was 0.5 and 1 ppb of Zn. All such
prepared samples (initial and those spiked by Zn) were analyzed according to the standard
addition method.
Experimental values obtained from spiked samples were compared to the “true” values,
corresponding to initial values with added known concentration values and expressed in
terms of their recovery (%). Determinations were made in double experimental sessions
(within a day and repeated the successive day, delayed by a minimum 24 h interval).
Linearity and Detection Limit
Linearity was studied for an extended concentration interval (up to 6 ppb) of Zn in the brain
microdialysate samples by standard addition methodology. Up to 12 Zn standard additions
were considered, each level being analyzed for three to five replicates. The linearity study
was repeated on solutions with a different Zn concentration (with matrix) in two successive
days. Before quantification the recorded voltammograms were transformed by a
background subtraction. The baseline was simulated by the 3rd degree polynomial. The
approximation intervals were chosen manually and were the same for all of the curves in
the set for calibration. The simulated background was calculated separately for each
voltammogram. This corrected data was then used to calculate linear regression parameters.
Additionally, the correlation coefficient and detection limit were obtained and given.
Results and Discussion
All optimization and validation experiments were realized using the pharmacological
samples which contain the matrix—brain microdialysate. It is very important that the
volume of the microdialysate obtained from one rat is minimal (not more than 5–30 μl).
The samples matched from successive rats are different, and the level of the zinc ions
concentration may be determined by only using the methodology described in this work.
Additionally, the sample may not be diluted because the zinc concentration is very low and
such an operation may have an unfavorable influence over the level of the uncertainty.
Therefore, there is no possibility to extend the volume of the sample. The brain
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microdialysates are kept from their being gathered for the experiment in a frozen state. The
defrosted samples may be preserved before their determination for only a short time. Both
the small volume of the microdialysate samples and low zinc concentration cause the
experiments to be very difficult.
Influence of pH on Zinc(II) Peak
During the measurements, organic matter (blood, serum, tissue, etc.) absorption takes place
on the working electrode, and this process distorts the ASV signal. Therefore, their removal
from the brain microdialysate samples analyzed by ASV is necessary. In this work, it was
conducted through the use of nitric acid. However, application of the acid for the
decomposition of the organic matter changes the pH of the measured solution and during
this process the background current rapidly increases (Fig. 1a). This current, which is
carried out by the reduction of the hydrogen ions, additionally reduces the signal-to-
background current ratio and obstructs interpretation of the recorded signals. But the zinc
peak potential and current is independent of the pH caused by the presence of nitric acid
(Fig. 1b). It is because of this that the addition of 1 μl of HNO3 (conc.) per 10 μl
microdialysate sample was used in this work. Such an addition of this acid guaranteed the
total degradation of the organic matter in all of the measured samples.
Optimization of DPASV Parameters
The optimization experiments were done in 5 ml of 0.05 M KNO3 supporting electrolyte
into which 50 μl of D1 microdialysate was added. This dialysate was prepared 24 h earlier
by the addition of 5 μl nitric acid. The Zn2+ concentration in the D1 microdialysate was
3.6 ppb, while the pH of the solution was 2.
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In order to adapt the DPASV method to nanomolar concentrations of Zn2+ three
parameters were optimized: step potential (Es), pulse amplitude (ΔE), and pulse time (tp= tw
(waiting time)+ ts (current sampling time)). Consequently, these parameters were investi-
gated. To optimize the conditions for Zn2+ measurements, the following instrumental
parameters were systematically verified: Es in the range 1–5 mV, ΔE in the range 10–
60 mV, and tp from 10 to 60 ms.
An increase of the potential step (in the given range) causes the increase on the peak’s
current by 50% in relation to the value for the lowest step (Fig. 2a). However, increasing Es
is then accompanied by the background current rising. As such, it is not suggested that the
Es>2 mV is applied. The step potential of 2 mV was applied in further work.
Next, the different pulse time was tested (Fig. 2b), which in this apparatus is closely
connected with the waiting time and sampling time. The best results (precision,
reproducibility, and the signal-to-background current ratio) were obtained for pulse width
40 ms, and this was the value chosen for the further work. In each case, tw= ts=20 ms
(waiting time=current sampling time). The height of the Zn peak strongly decreases with
the increasing time tp but also background current decreases.
In further tests, it was discovered that the peak current of Zn2+ was similar for both
negative and positive amplitude values. The best results (signal-to-background current
ratio) were obtained for the pulse amplitude −30 mV. Higher pulse amplitude (absolute
value greater than 30 mV) caused major growth of the background current. The peak
potential of zinc was shifted to negative potentials with increased pulse amplitude (ca.
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Fig. 2 Optimization of measuring parameters, data obtained for the D1 sample: a potential step, b pulse time
(waiting time+current sampling time), c pulse potential, and d accumulation time. The gray arrows point to
the optimal value of the considered parameter, which was further applied in Zn determinations
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28 mV in the given range). For ΔE changing in the range 10–60 mV, the width of the peak
at half-height for Pb2+ was 44 mV. The pulse amplitude of −30 mV was chosen (Fig. 2c).
Optimization of Accumulation Time and Potential
The influence of preconcentration potential and time are always important factors in the
sensitivity and detection limit of the ASV method. The influence of the accumulation
potential was studied in the range from −1.20 to −1.05 V with the supporting electrolyte
spiked with brain microdialysate. The repeatability and the magnitude of the analytical
signal were found to be independent of the accumulation potential in the given range. The
accumulation potential −1.15 V was chosen.
The accumulation time was changed from 1 to 150 s (Fig. 2d). The peak current for
the supporting electrolyte containing brain microdialysate increased linearly with the
accumulation times. For further study, the accumulation time of 60 s was chosen. The larger
accumulation times are impractical in experiments.
Validation Parameters
Further experiments were carried out using four different microdialysate samples: D2, D3,
D4, and D5, which are characterized by different zinc concentrations. The measurements
were done in 5 ml of 0.05 M KNO3 supporting electrolyte into which 20 μl of
microdialysate was added. The pH of the solution was 2.4. This dialysate was prepared 24 h
earlier by the addition of 2 μl nitric acid.
Linearity The linearity study was realized by the standard addition calibration and its
results are presented in Table 1. In the case of dialysates D2, D3, and D4, the standard of
concentration 1 ppb was added three times. Here, each calibration point was prepared in
triplicate. In the case of the dialysate D5, the standard was added 12 times, and the
concentration of one standard was 0.5 ppb. Here, each calibration point was measured five
times. Each analysis was repeated on the next day. The results were calculated by linear
regression. It may be observed that the sensitivity changed insignificantly from 5.0 to
6.8 nA ppb−1 in relation to the sample and the day of analysis. The standard deviation of the
slope is not greater than 0.1 nA. A good linearity is evident from the values of the
correlation coefficients r ¼ 0:9988 0:9999 (Table 1). The correlation coefficient was
lower than 0.999 and obtained 0.9988 only in one case. This method presented linearity in
the range of 1–6 ppb. Additionally it was observed that the zinc peak potential is
independent of the concentration of zinc ions.
Detection Limit The achieved limit of detection (LOD) following from the Zn
preconcentration at the time of 60 s was ca. 0.1–0.3 ppb. The achieved LOD revealed the
high sensitivity of the described voltammetric method.
Precision The high sensitivity of an analytical method is usually accompanied by very
good precision. The analytical performance of the described DPASV voltammetric method
was evaluated as standard deviation and coefficient of variability. The experiments were
realized in the presence of the matrix. The repeatability of the Zn peak height recorded for
the dialysate (four different concentration) without standard addition was tested. For brain
microdialysates D2, D3, and D4, three replicates were recorded, while five replicates were
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recorded for D5. Each test was repeated on the next day. The achieved CVof no more than
4.2% confirmed the excellent precision of the described method (Table 2). The very good
repeatability of the recorded signals was also observed after standard additions.
The validation of precision was continued by the realization of the whole Zn
determination process which additionally was repeated on another day. The experiments
were repeated three times for samples D2, D3, and D4 and five times for dialysate D5. The
obtained CV in this situation was not greater than 7.6% (Table 3). The obtained variability
of the whole determination process is not so low as in the repeatability of the Zn peak high.
It is caused by the influence of the dispersion of the calibration points around the regression
line. This lack of consistency introduced the variability of the final result of concentration.
Accuracy Samples for the recovery test were prepared as follows. Firstly, the whole
calibration process was realized for the dialysate. Next, the sample was spiked by, initially,
0.5 ppb of Zn(II) and, next, 1.0 ppb. In each case, the standard addition calibration was
Table 2 The study of the repeatability of Zn peak height carried out on samples with a matrix through the
standard addition method
Analyte Zn peak height found for replicate/μA Mean peak height/
μA
Standard deviation of
mean/μA
CV/%
1st 2nd 3rd 4th 5th
D2 0.0085 0.0084 0.0088 − − 0.0086 0.0002 2.3
D2’ 0.0085 0.0085 0.0086 − − 0.0085 0.0001 1.1
D3 0.0068 0.0070 0.0071 − − 0.0070 0.0002 2.9
D3’ 0.0070 0.0071 0.0075 − − 0.0072 0.0003 4.2
D4 0.0047 0.0046 0.0047 − − 0.0047 0.00006 1.2
D4’ 0.0053 0.0054 0.0054 − − 0.0054 0.00006 1.1
D5 0.0049 0.0051 0.0050 0.0053 0.0052 0.0051 0.00015 2.9
D5’ 0.0042 0.0043 0.0043 0.0043 0.0042 0.0043 0.00004 0.9
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Table 1 The linearity study carried out on samples with a matrix through the standard addition method
Analyte No. of
standard
additions
Mean slope/
μA ppb−1
Standard
deviation of
b / μA ppb−1
Mean
intercept/
μA
Standard
deviation of
a / μA
Correlation
coefficient
Detection
limit/ppb
m b SDb a SDa r DL
D2 3 0.0050 0.00006 0.0085 0.0001 0.9994 0.1
D2’x 3 0.0055 0.00006 0.0083 0.0001 0.9995 0.1
D3 3 0.0054 0.00004 0.0070 0.00008 0.9997 0.1
D3’ 3 0.0050 0.00006 0.0071 0.00001 0.9993 0.1
D4 3 0.0061 0.0001 0.0050 0.0002 0.9988 0.2
D4’ 3 0.0052 0.00005 0.0059 0.00008 0.9997 0.1
D5 12 0.0059 0.00003 0.0052 0.0001 0.9999 0.1
D5’ 12 0.0068 0.00008 0.0036 0.0003 0.9994 0.3
x Prim denotes experiments done on another day
realized. The considered dialysates were: D2, D3, and D4. Recordings were done with three
replicates. Each test was repeated on the next day. The results were analyzed by linear
regression. Data recovery values from the accuracy study are presented in Table 4. The
obtained values are localized in the interval ca. 82–110%. This result of the test may be
accepted because of a very low concentration of the analyte (not greater than 2 ppb).
Conclusions
The main goal of this work was the optimization and validation of the anodic stripping
voltammetry method for the determination of Zn2+ ions in brain microdialysate samples.
The optimal experimental variables as well as accumulation parameters were investigated
as: potential increment 2 mV, time of potential increment 40 ms, scan pulse amplitude dE
−30 mV and an accumulation potential Eacc 60 ms at −1.15 V using a 50 mM KNO3
solution (pH 2.4) as a supporting electrolyte. The optimized method was validated and was
found to be very sensitive, linear, precise, and accurate. Mean recovery 82–110% was
achieved, precision expressed by CV not greater than 7.6%, and the linearity given by
correlation coefficient not lower than 0.9988. The measured repeatability of the peak height
was not greater than 4.2%. The LOD was 0.1 ppb.
Table 3 The precision study of Zn determination carried out on samples with a matrix through the standard
addition method
Analyte Zn concentration found for
replicate/ppb
Mean Zn concentration/
ppb
Standard deviation of mean/
ppb
CV/%
1st 2nd 3rd 4th 5th
D2 1.70 1.65 1.75 − − 1.70 0.05 2.9
D2’ 1.50 1.50 1.56 − − 1.52 0.04 2.6
D3 1.25 1.33 1.32 − − 1.30 0.05 3.8
D3’ 1.33 1.44 1.54 − − 1.44 0.11 7.6
D4 0.82 0.77 0.80 − − 0.80 0.03 3.8
D4’ 1.09 1.11 1.10 − − 1.10 0.02 1.8
D5 0.96 0.96 0.93 1.00 1.00 0.97 0.03 3.1
D5’ 0.72 0.75 0.73 0.72 0.72 0.73 0.02 2.7
Table 4 The accuracy study of Zn determination carried out on samples with a matrix through the standard
addition method
Analyte Initial Zn concentration/ppb Recovery/% (first day) Recovery/% (another day)
0.5 ppb added 1.0 ppb added 0.5 ppb added 1.0 ppb added
D2 1.70 82.2 109.7 89.9 97.7
D3 1.30 84.1 92.2 83.1 94.0
D4 0.80 92.6 106.0 88.7 98.0
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These results demonstrate, for the first time, detailed characteristics of the determina-
tion of zinc in the brain microdialysate fluid by the ASV method, which is an indication
for using this method for future zinc determinations in biological fluids. This already
validated method may be applied in a wide range of physiological and pharmacological
studies which focus on very low zinc concentration/alteration in various compartments of
the body.
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